Evaluation of the Combined Effect of Recombinant High-Density Lipoprotein Carrier and the Encapsulated Lovastatin in RAW264.7 Macrophage Cells Based on the Median-Effect Principle-Reference-Cited by-同舟云学术

Evaluation of the Combined Effect of Recombinant High-Density Lipoprotein Carrier and the Encapsulated Lovastatin in RAW264.7 Macrophage Cells Based on the Median-Effect Principle

Published:2018-01-30 Issue:3 Volume:15 Page:1017-1027
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Jiang Cuiping¹,Zhao Yi¹,Yang Yun¹,He Jianhua¹,Zhang Wenli¹,Liu Jianping¹^ORCID

Affiliation:

1. Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210008, PR China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Jiangsu Province

Priority Academic Program Development of Jiangsu Higher Education Institutions

Zhejiang Huahai Pharmaceutical Co., Ltd.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.7b00923

Reference50 articles.

1. Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery

2. Apolipoprotein A-I/HDL Infusion Therapy for Plaque Stabilization-Regression: A Novel Therapeutic Approach

3. Reverse cholesterol transport, high density lipoproteins and HDL cholesterol: recent data

4. HDL-Mimetic PLGA Nanoparticle To Target Atherosclerosis Plaque Macrophages

5. Atheroprotective Effects of HDL: Beyond Reverse Cholesterol Transport

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROS-Responsive Prodrug Micelle Co-Delivery System for Synergistic Antiatherosclerotic Therapy;Molecular Pharmaceutics;2023-07-31

2. Reactive oxygen species (ROS)-responsive size-reducible nanoassemblies for deeper atherosclerotic plaque penetration and enhanced macrophage-targeted drug delivery;Bioactive Materials;2023-01

3. A green-inspired method to prepare non-split high-density lipoprotein (HDL) carrier with anti-dysfunctional activities superior to reconstituted HDL;European Journal of Pharmaceutics and Biopharmaceutics;2023-01

4. Hydroxypropyl-β-cyclodextrin/Oridonin and Trehalose loaded nanovesicles attenuate foam cells formation and regulate the inflammation;European Polymer Journal;2022-11

5. Cyclodextrin boostered-high density lipoprotein for antiatherosclerosis by regulating cholesterol efflux and efferocytosis;Carbohydrate Polymers;2022-09